Resmed Announces Small, Easy to Use Home Sleep Apnea Test, NightOwl(TM), Now Available Across the US
(NYSE:RMD),(AUST:RMD.AX), SAN DIEGO, April 03, 2025 (GLOBE NEWSWIRE) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced its home sleep apnea test, NightOwl(TM), is now available across the United States. NightOwl is an FDA-cleared home sleep apnea test (HSAT) designed to […]